Edition:
United States

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

76.23EUR
11:35am EST
Change (% chg)

€0.19 (+0.25%)
Prev Close
€76.04
Open
€76.43
Day's High
€76.75
Day's Low
€76.09
Volume
637,261
Avg. Vol
680,641
52-wk High
€85.65
52-wk Low
€70.00

Select another date:

Fri, Jan 13 2017

BRIEF-Fresenius Medical Care: U.S. court grants temporary restraining order

* U.S. court has granted a temporary restraining order (TRO) requested by dialysis patients citizens, Fresenius Medical Care, Davita, and US Renal, with the support of the American kidney foundation

BRIEF-Cytosorbents and Fresenius Medical Care agree to broaden terms of existing partnership

* Fresenius Medical Care, Cytosorbents agreed to broaden terms of existing partnership,to add expansive co-marketing deal for Cytosorb

Fresenius Medical, DaVita subpoenaed over premium assistance

BERLIN/NEW YORK German's Fresenius Medical Care and U.S. rival DaVita Inc said they had both received subpoenas from federal prosecutors investigating their ties with a charity that helps patients pay for kidney dialysis.

UPDATE 2-Fresenius Medical, DaVita subpoenaed over premium assistance

BERLIN/NEW YORK, Jan 7 German's Fresenius Medical Care and U.S. rival DaVita Inc said they had both received subpoenas from federal prosecutors investigating their ties with a charity that helps patients pay for kidney dialysis.

Fresenius Medical files suit over US rule change on renal disease care

BERLIN, Jan 7 German kidney dialysis provider Fresenius Medical Care (FMC) said it is challenging a U.S. move to end assistance to patients with end-stage renal disease (ESRD) that it said could have a "material adverse affect" on its business.

BRIEF-zfhn Zukunftsfonds Heilbronn sells XENIOS to Fresenius Medical Care

* Says has sold medical technology company XENIOS AG to Fresenius Medical Care AG & Co. KGaA

UPDATE 1-Fresenius group benefits from North America business, cost cuts

* Improvements driven by strong North America sales (Recasts throughout, adds details)

Fresenius SE notches up lower end of 2016 earnings guidance

FRANKFURT, Oct 27 German healthcare group Fresenius SE slightly upped its earnings guidance on Thursday, citing strong prospects for the remaining months of 2016 and a solid third-quarter performance.

BRIEF-Fresenius Medical Care confirms 2016 outlook

* Group revenue +9% (+9% at constant currency), driven by a strong performance in health care services

BRIEF-Germany's FMC buys Indian dialysis group Sandor Nephro

* Says acquires dialysis service provider Sandor Nephro services in India, which is expected to generate around $3 mln in 2016 revenues

Select another date: